Definium Therapeutics (DFTX) Interest & Investment Income (2023 - 2026)

Definium Therapeutics (DFTX) has 4 years of Interest & Investment Income data on file, last reported at $3.5 million in Q1 2026.

• Interest & Investment Income for Q1 2026 came in at $3.5 million, up 42.09% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.0 million (down 2.85% YoY), and the FY2025 annual result was $11.0 million, down 5.17% from the prior year.
• Interest & Investment Income fell to $3.5 million in Q1 2026 per DFTX's latest filing, from $3.5 million in the prior quarter.
• Over five years, Interest & Investment Income peaked at $3.5 million in Q3 2024 and troughed at $1.3 million in Q4 2023.
• A 4-year average of $2.4 million and a median of $2.4 million in 2025 frame the typical range for Interest & Investment Income.
• The sharpest annual moves came in 2024 and 2025: Interest & Investment Income surged 143.97% in 2024, then slumped 35.5% in 2025.
• A 4-year view of Interest & Investment Income shows it stood at $1.3 million in 2023, then surged by 143.97% to $3.3 million in 2024, then grew by 6.47% to $3.5 million in 2025, then decreased by 0.97% to $3.5 million in 2026.
• Business Quant data shows DFTX's Interest & Investment Income at $3.5 million in Q1 2026, $3.5 million in Q4 2025, and $2.3 million in Q3 2025.